Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Joanna Kufel-Grabowska"'
Autor:
Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk
Publikováno v:
Nowotwory. Journal of Oncology. 72:74-79
Autor:
Joanna Kufel-Grabowska, Maria Litwiniuk, Mikołaj Bartoszkiewicz, Paweł Burchardt, Piotr Jedrzejczak
Publikováno v:
Nowotwory. Journal of Oncology. 71:263-266
Introduction. Breast cancer (BC) is the most common female neoplasm in Poland and worldwide, yet up to 7% of all cases is diagnosed < 40 years of age. The increased BC morbidity rate in this age group as well as hope for late maternity need special a
Publikováno v:
Contemporary Oncology
Introduction In the era of the COVID-19 pandemic overlapping with the influenza season, the number of infections with the abovementioned viruses may result in overload in the healthcare system, difficulties in the diagnosis of respiratory diseases, p
Autor:
Milena Lachowicz, Rodryg Ramlau, Joanna Kufel-Grabowska, Mikołaj Bartoszkiewicz, Krzysztof Łukaszuk
Publikováno v:
Nowotwory. Journal of Oncology. 71:232-237
Introduction. Breast cancer is the most common cancer in women – both in Poland and around the world. In terms of the mortality rate, it subsides brest cancer with lung cancer. In 2018, almost 2 million new cases were reported worldwide, and almost
Publikováno v:
Breast Disease. 40:33-41
BACKGROUND: Breast cancer is the most common cancer in women in Poland and worldwide. Due to growing morbidity and mortality, patients are looking for new therapeutic options. Clinical trials give cancer patients a chance to access innovative treatme
Autor:
Joanna Kufel-Grabowska, Amira Podolak, Mikołaj Bartoszkiewicz, Daniel Maliszewski, Dominika Ossowska, Robert Spaczynski
Publikováno v:
Cancer Research. 83:P6-05
Introduction Genetic background is rarely the cause of breast cancer incidence. Mutations in genes that increase the risk of breast cancer (most commonly BRCA1/2) are diagnosed in about 5-10% of patients. The lifetime risk of breast cancer in BRCA1/2
Autor:
César A. Rodríguez, Luigi Cavanna, Joanna Kufel-Grabowska, Priya Gokani, Mark Lillie, Jane Hippenmeyer, Antonio Bernardo, Tevy San, Grażyna Suchodolska, Isaura Fernandez Perez
Publikováno v:
Cancer Research. 81:PS10-50
Background: Over recent years, therapeutic biosimilars have started to be licensed as oncology treatments in both palliative and potentially curative settings, but little is known about their uptake and usage in routine clinical practice. ABP 980 is
Autor:
Joanna, Kufel-Grabowska, Amira, Podolak, Daniel, Maliszewski, Mikołaj, Bartoszkiewicz, Rodryg, Ramlau, Krzysztof, Lukaszuk
Publikováno v:
Journal of clinical medicine. 11(14)
Breast cancer is the most commonly diagnosed cancer worldwide and the fifth leading cause of cancer death. In 2020, there were 2.3 million new cases, and 685,000 women died from it. Breast cancer among young women under 40 years of age accounts for 5
Publikováno v:
Nowotwory. Journal of Oncology. 71:162-164
Pregnancy-associated breast cancer (PABC) is the most common malignancy of pregnancy, affecting 1 in 3000 women. Due to the increased size and density of the breast tissue during pregnancy and lactation, diagnosis and treatment are commonly delayed.
Publikováno v:
OncoReview. 10:67-76